Efficacy of Biejiajian Pill on Intestinal Microbiota in Patients with Hepatitis B Cirrhosis/Liver Fibrosis: A Randomized Double-Blind Controlled Trial

Reyanning Mixture on Asymptomatic or Mild SARS-CoV-2 Infection in Children and Adolescents: A Randomized Controlled Trial

Center of Liver Diseases Division 3, Beijing Ditan Hospital, Capital Medical University, Beijing, China;Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China;National Center for Infectious Diseases, Beijing, China;Peking University Ditan Teaching Hospital, Beijing, China;Central of Integrated Chinese and Western Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China;China Traditional Chinese Medicine Holdings Co. Limited, Guangzhou, China

Department of Emergency, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China;Acupuncture and Massage College, Shanghai University of Traditional Chinese Medicine, Shanghai, China;Department of Health Management, The First Affiliated Hospital of Nanchang University, Nanchang, China;Jiangxi Provincial Traditional Chinese Medicine Nephropathy Clinical Research Center, Jiujiang Hospital of Traditional Chinese Medicine, Jiujiang, Jiangxi Province, China;Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China;Institute of Critical Care, Shanghai University of Traditional Chinese Medicine, Shanghai, China